Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Hematology

Building Your Care Team and Long-Term Monitoring

At a Glance

After POEMS syndrome treatment, long-term follow-up combines a coordinated team with regular checks of VEGF, monoclonal proteins, blood counts, kidney and hormone function, nerve recovery, and daily abilities. VEGF trends help, but one result does not diagnose relapse.

Because POEMS syndrome affects so many parts of the body, your care cannot be managed by a single doctor. Success in the long term depends on two things: a multidisciplinary team that knows how to communicate and a personalized monitoring schedule that tracks how your body is responding to treatment [1][2].

Building Your Care Team

In a disease as rare as POEMS, it is helpful to have a team that is familiar with the condition or willing to consult with major referral centers [3]. Your care roster should ideally include:

  • The Hematologist (Lead): A specialist in plasma cell disorders. They manage the primary disease and oversee chemotherapy or stem cell transplants [1].
  • The Neurologist: They focus on your nerve recovery, performing tests to see if your nerve fibers are healing [4].
  • The Endocrinologist: They monitor and manage your thyroid, adrenal glands, and sex hormones [5].
  • Physical and Occupational Therapists: These experts help you translate medical recovery into functional independence, such as walking safely, managing neuropathic pain, and using assistive devices [6].

Long-Term Monitoring Strategy

Once your initial treatment (like radiation or a transplant) is complete, you move into a surveillance phase to monitor your recovery and watch for any signs of relapse [1][7].

The Role of VEGF Monitoring

Your VEGF level is an important marker for tracking POEMS. It typically falls after successful treatment.

  • Understanding the Numbers: In specific research studies, patients whose serum VEGF dropped below a threshold of 1,040 pg/mL at six months had a higher chance of long-term, relapse-free survival [7][8]. However, this is a research cutoff, not a universal treatment target.
  • Consistency Matters: Serum and plasma VEGF values are not interchangeable, and different labs use different methods. It is crucial to use the same laboratory over time to accurately track your trend [9].
  • The Big Picture: A single high VEGF reading does not automatically mean a relapse, and a single lab result should never trigger a treatment change on its own. Your doctor will look at the whole picture: your clinical symptoms, nerve function, organ health, and other blood tests [9].

Monitoring Intervals

There is no single schedule for all patients. As a general example, in the first year after treatment, you may have blood work every 3 to 6 months. Once stable, this may stretch to every 6 to 12 months [1][8]. These visits are individualized but typically include:

  1. Monoclonal Protein Studies: Such as SPEP and immunofixation to check the plasma cell clone [10].
  2. VEGF Levels: Using a consistent assay [7].
  3. Organ Function & Safety: Checking Complete Blood Counts (CBC), kidney function, urine protein, and hormone levels [11][12].
  4. Clinical Assessment: Evaluating neuropathy, functional status, and cardiopulmonary health.

Life After Treatment: What to Expect

It is normal to feel “scan anxiety” or worry every time you feel a new symptom. However, the long-term outlook for many patients is encouraging [13].

  • Neurologic Healing is Slow: Nerves heal much slower than other tissues. It can take months or even years to see the full extent of your neurologic improvement [1][2]. Do not be discouraged if recovery feels slow.
  • Functional Gains: Many patients in cohort studies experience life-changing improvements, with some regaining the ability to walk after severe disability [6]. While some may still need mobility aids or have residual numbness, many achieve a high level of independence [6][14].
  • Living Well: Survivorship involves more than just lab results. Work with your care team on strategies for fall prevention, managing neuropathic pain, coping with fatigue, and addressing the emotional toll of a rare disease diagnosis [1].

Common questions in this guide

Who should be involved in my POEMS syndrome care?
A hematologist often leads care for the plasma cell disorder, while a neurologist monitors nerve recovery and an endocrinologist manages hormone-related problems. Physical and occupational therapists can help with walking, pain, mobility aids, and daily independence. A specialist center may be consulted when local experience is limited.
How often will I need follow-up tests after POEMS treatment?
There is no single schedule for everyone. As a general example, blood work may be done every 3 to 6 months during the first year and every 6 to 12 months once the condition is stable. Your doctors will adjust the timing based on your treatment, symptoms, test results, and overall health.
What does my VEGF level tell doctors about POEMS syndrome?
VEGF is a blood marker that often falls after successful POEMS treatment and can help doctors track the disease over time. Serum and plasma results cannot be compared directly, so using the same laboratory and testing method is important. One high result does not by itself prove relapse or justify changing treatment.
What tests are used to monitor POEMS syndrome after treatment?
Follow-up may include tests for the abnormal plasma cell protein, such as serum protein electrophoresis and immunofixation, along with VEGF levels. Doctors may also check blood counts, kidney function, urine protein, and hormone levels. Visits commonly include assessments of nerve function, daily abilities, and heart and lung health.
How long can nerve recovery take after POEMS treatment?
Nerves heal slowly, so improvement may continue for months or years after treatment. Some people regain major abilities such as walking, while others may have lasting numbness or need mobility aids. Rehabilitation, fall prevention, pain management, and tracking small functional changes can support recovery.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with POEMS syndrome have you personally managed, or do you consult with a specialized center?
  2. 2.How often will we be checking my VEGF levels, and can we ensure we use the same laboratory and assay method each time?
  3. 3.If my VEGF level stays elevated after treatment, how will we use my other clinical symptoms and tests to decide our next steps?
  4. 4.Who on the team is responsible for coordinating between my hematologist, neurologist, and endocrinologist?
  5. 5.Since my nerves heal slowly, how will we track my physical progress—will we use a specific functional scale?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Comprehensive Diagnosis and Management of POEMS Syndrome.

    D'Sa S, Khwaja J, Keddie S, et al.

    HemaSphere 2022; (6(11)):e796 doi:10.1097/HS9.0000000000000796.

    PMID: 36340912
  2. 2

    Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.

    Khouri J, Nakashima M, Wong S

    JAMA oncology 2021; (7(9)):1383-1391 doi:10.1001/jamaoncol.2021.0586.

    PMID: 34081097
  3. 3

    Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey.

    Suichi T, Misawa S, Beppu M, et al.

    Neurology 2019; (93(10)):e975-e983 doi:10.1212/WNL.0000000000008062.

    PMID: 31371568
  4. 4

    Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.

    Keddie S, Foldes D, Caimari F, et al.

    Neurology 2020; (95(3)):e268-e279 doi:10.1212/WNL.0000000000009940.

    PMID: 32606227
  5. 5

    Prevalence and Course of Endocrinopathy in POEMS Syndrome.

    Caimari F, Keddie S, Lunn MP, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(6)):2140-2146 doi:10.1210/jc.2018-01516.

    PMID: 30239770
  6. 6

    Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.

    Karam C, Klein CJ, Dispenzieri A, et al.

    Neurology 2015; (84(19)):1981-7 doi:10.1212/WNL.0000000000001565.

    PMID: 25878176
  7. 7

    Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.

    Misawa S, Sato Y, Katayama K, et al.

    BMJ open 2015; (5(11)):e009157 doi:10.1136/bmjopen-2015-009157.

    PMID: 26560063
  8. 8

    Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome.

    Gentile F, Terenghi F, Doneddu PE, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024; (45(2)):727-733 doi:10.1007/s10072-023-07064-5.

    PMID: 37702830
  9. 9

    Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case report.

    Kannan A, Zhuo Y, Banerjee R

    EJHaem 2024; (5(4)):842-844 doi:10.1002/jha2.965.

    PMID: 39157604
  10. 10

    Monoclonal-related neuropathies: diagnosis, prognosis, and outcomes.

    Jaccard A, Magy L, Arnulf B, et al.

    Hematology. American Society of Hematology. Education Program 2025; (2025(1)):385-392 doi:10.1182/hematology.2025000728.

    PMID: 41348001
  11. 11

    Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome.

    Ye W, Wang C, Cai QQ, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016; (31(2)):275-83 doi:10.1093/ndt/gfv261.

    PMID: 26130736
  12. 12

    Endocrine Evaluation in POEMS Syndrome: A Cohort Study.

    Yang H, Zhao H, Gao X, et al.

    Frontiers in endocrinology 2020; (11()):536241 doi:10.3389/fendo.2020.536241.

    PMID: 33193075
  13. 13

    Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS Syndrome.

    Li AA, Gao XM, Zhao H, et al.

    Transplantation and cellular therapy 2024; (30(2)):207.e1-207.e7 doi:10.1016/j.jtct.2023.11.001.

    PMID: 37931801
  14. 14

    Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.

    Kawajiri-Manako C, Sakaida E, Ohwada C, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018; (24(6)):1180-1186 doi:10.1016/j.bbmt.2018.01.026.

    PMID: 29409882

This page provides general information about building a POEMS syndrome care team and monitoring after treatment for informational purposes only and does not constitute medical advice. Your hematologist and other specialists should tailor testing, VEGF interpretation, and rehabilitation to your situation.

Get notified when new evidence is published on POEMS syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.